Pharmafile Logo

Medscape at ASH 2025: Landmark Value Through the Medscape AI Debut and Five Educational Symposia

December 1, 2025 |  

- PMLiVE

For decades, Medscape has been the brand physicians trust. Now, Medscape is forging a new path into the future at ASH 2025 with the launch of Medscape AI — the first and only medical-grade Generative AI experience that integrates Medscape’s proprietary content, peer-reviewed literature, and real-time medical news to deliver timely, trustworthy, specialty-specific insights that support informed decision-making.

Medscape AI marks a transformation from a single search tool to a robust platform of integrated AI-powered solutions for HCPs. This shift emphasizes integration, bringing together multiple AI capabilities designed to support clinicians in all aspects of their practice, beyond just search, making the evolution substantial and future-oriented with exciting developments to come. 

Among the proven benefits of Medscape AI:

  • Reliability: Clinically Vetted Sources, Transparent By Design
    • Built on both Medscape’s trusted proprietary content and evidence from 400+ of the most prestigious peer-reviewed journals across a wide range of specialties — spanning oncology, cardiology, dermatology, internal medicine, and beyond — with no unverified material from the open internet
    • AI responses are traceable, transparent, and supported by citations 
  • Recency: Always Current and Continuously Updated
    • Integrates verified real-time news, research updates, and guideline changes
    • Daily and weekly editorial oversight ensures outputs reflect the latest evidence 
  • Relevance: Aligned to Practice and Patient Care
    • Jointly built with practicing clinicians to bridge the gap between AI innovations and clinical reality
    • Synthesized insights tuned to each specialty, workflow, and clinical context
    • Guidance supports differential diagnosis, treatment decisions, and next-step care
    • Integrated across the Medscape experience, including the industry-leading Medscape newsreader and point-of-care decision support tools  
  • Time-Saving Clinical Efficiency
    • Digestible, actionable responses free up clinicians to focus more on patient care and less time searching and reviewing literature

“As AI becomes essential to modern clinical practice, it not only needs to unlock unmatched value to our users, it must also meet the rigorous standards clinicians require: accurate, current, and evidence-based,” said Bob Brisco, CEO of Medscape’s parent company, Internet Brands. “Medscape AI delivers this and more. It cuts through the information overload plaguing healthcare professionals, synthesizing evidence instantly to drive better patient outcomes. It’s clinical precision in your pocket – expert guidance that’s tailored to meet your exact query, grounded in evidence, and powered by Medscape’s human-validated compendium of medical expertise.”

Medscape  is advancing medical education through data-driven insights and innovative technology . Focused on the oncology and hematology community at ASH 2025, Medscape Education delivers transformative CME solutions that go beyond knowledge transfer to impact real-world clinical behavior, and, most critically, patient outcomes. Between 2023 and 2025 Medscape’s learning design and scientific content teams have delivered 102 programs in hematology, reaching 836,531 learners, who are potentially impacting over 3 million patients per month. 

 Visit booth #443 to explore our comprehensive hematology education offerings and get hands-on experience with the new Medscape AI feature!

Educational Symposia

Join us on Friday, December 5, 2025 for 5 Medscape Oncology educational symposia designed to help clinicians translate the latest clinical data into practice. Register here.

  • Rare Clinical Spotlight: Exploring Castleman Disease, Cold Agglutinin Disease and Acute Intermittent Porphyria
    • Time: 11:30 AM – 1:00 PM ET
    •  Hyatt Regency Orlando, 9801 International Drive, Orlando, Florida, 32819
    • Room: Plaza International HIJK
  • Targeted Therapies in R/R PCNSL: New Frontiers in Treatment and Management
    • Time: 11:30 AM – 1:00 PM ET
    • Hyatt Regency Orlando, 9801 International Drive, Orlando, Florida, 32819
    • Room: Plaza International DEFG 
  • Tailoring Bispecific Antibodies to Individualize R/R Follicular Lymphoma Care: A Case-Based Discussion
    • Time: 11:30 AM – 1:00 PM ET
    •  Orange County Convention Center, 9800 International Drive, Orlando, FL, 32819
    • Room: W311 EFGH
  • Personalizing Relapsed/Refractory DLBCL With Bispecific Antibody Therapy: A Case-Based Discussion
    • Time: 3:30 PM – 5:00 PM ET
    •  Orange County Convention Center, 9800 International Drive, Orlando, FL, 32819
    • Room: W311 EFGH
  • Acute Hepatic Porphyria: Bridging Gaps for Better Diagnosis and Management
    • Time: 3:30 PM – 5:00 PM ET
    • Hyatt Regency Orlando, 9801 International Drive, Orlando, Florida, 32819
    • Room: Plaza International HIJK

ASH Abstract Publication 

Michelle Worst, PharmD, BCOP, MBA, CHCP has an online abstract accepted at ASH 2025. The abstract, titled “Assessing the influence of live and online enduring CME activities presented at the 66th ASH annual meeting on hematology/oncology specialists using pre-/post-education evaluations,” will be published online-only on the ASH abstracts site in the November supplemental issue of Blood

For more information, please contact Jelena Spyropoulos.

This content was provided by Medscape Education

Company Details

 Latest Content from  Medscape Education 

The Most Important Person in the Room—A Look at Patient -Centricity at EHA

Across all of healthcare, a greater focus is being placed on patient centricity in order to improve outcomes and enhance patients’ quality of life. Although patient centricity is necessary in...

Innovation in Education Leads to Positive Outcomes at EAN 2023

The Medscape team recently returned from the 9th Annual Congress of the European Academy of Neurology (EAN) in Budapest, Hungary. Among the various highlights of the congress, the team showcased...

The Lasting Impact of Cytomegalovirus Education 

Education on the signs, symptoms, and potential complications of cytomegalovirus (CMV) is in need of constant development, as this common disease affects nearly 1 in 3 children by age 5...

Medscape Education Publishes the Results of Multinational, Multispecialty Survey of Physicians on Rare Disease Educational Needs

Medscape Education has published the results of a global survey of its kind, assessing the educational needs of physicians on rare diseases. This survey of 978 clinicians worldwide across 16...

Medscape Showcases Outcomes in Austria for EASL Congress

Medscape recently attended the EASL Congress in Austria, where they successfully showcased the outcomes of their Wilson Disease education program. One of their achievements was presenting a poster on "Online...

Medscape is Bringing Outcomes to the #HomeOfNeurology

Budapest, Hungary is set to become Medscape's next destination as they gear up for the highly anticipated 9th Annual Congress of the European Academy of Neurology. As an integral part...

Medscape Education: ACOG 2023 Publication

Medscape Education is making a difference! We are wrapping CMV Awareness Month with a look at the impact of CMV education on OB/GYN learners. Take a look as Medscape Senior...

It’s the Era of Outcomes at ERA 2023

The Medscape team has bid farewell to the beautiful city of Milano, Italy and our European nephrology colleagues. The team was thrilled to meet up with so many ground-breaking clinicians,...

International NASH Day 2023

Shari Dermer, PhD of Medscape Education, hosted Michael Betel, Founder and President of Fatty Liver Alliance, in an engaging conversation around the importance of NASH awareness, diagnosis, and prognosis. Listen...

Shining a Spotlight on Patient Centricity in Frankfurt for EHA

The Medscape Oncology team has made their way back from Frankfurt, Germany after another successful EHA 2023 conference. While at the event, the team interacted with conference attendees at the...